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ABSTRACT  Two monoclonal antibodies have been produced against chick type V collagen and 
shown to be highly specific for separate, conformational  dependent determinants within this 
molecule. When used for immunocytochemical tissue localization, these antibodies show that 
a  major site for the  in situ  deposition of  type V  is within  the extracellular matrices of  many 
dense connective tissues. In these, however, it is largely in a form unavailable to the antibodies, 
thus  requiring  a  specific  "unmasking"  treatment  to  obtain  successful  immunocytochemical 
staining. The specificity of  these two  IgG  antibodies was determined  by  inhibition  ELISA, in 
which only type V  and no other known collagen shows inhibition. In  ELISA,  mixtures of  the 
two antibodies give an additive binding reaction to the collagen, suggesting that each is against 
a different  antigenic determinant.  That  both  antigenic determinants  are conformational  de- 
pendent, being either in, or closely associated with, the collagen helix is demonstrated  by the 
loss of antibody binding to molecules that have been thermally denatured. The temperature at 
which this occurs, as assayed by inhibition ELISA, is very similar to that at which the collagen 
helix melts, as determined  by optical  rotation. This gives strong additional evidence that the 
antibodies are directed against the collagen. The antibodies were used for indirect immunoflu- 
orescence analyses of cryostat sections of corneas and other organs from 17 to 18-day-old chick 
embryos.  Of  all tissues examined, only Bowman's  membrane gave a strong staining reaction 
with cryostat sections of  unfixed  material. Staining in other areas of the cornea and in other 
tissues was  very  light or  nonexistent. When,  however,  sections were  pretreated  with  pepsin 
dissolved in dilute HAc or, surprisingly, with the dilute HAc itself dramatic new staining by the 
antibodies was observed  in  most  tissues examined. The staining, which  was  specific for  the 
anti-type  V  collagen  antibodies,  was  largely  confined  to  extracellular  matrices  of  dense 
connective tissues. Experiments using protease inhibitors suggested that the "unmasking" did 
not involve proteolysis. We do not yet know the mechanism of this unmasking; however, one 
possibility  is  that  the  dilute  acid  causes  swelling  or  conformational  changes  in  a  type-V 
collagen-containing supramolecular structure.  Further studies should  allow  us to  determine 
whether this is the case. 
Within both developing embryos and  adult organisms, most 
cells and tissues are intimately associated with some form of 
collagenous extracellular matrix. Such matrices fall into two 
general categories: (a)  the  stromas,  which  generally become 
populated with mesenchymal cells and consist largely of extra- 
cellular materials having structural and supportive roles within 
tissues and organs, and  (b) the basement membranes,  which 
are aceUular sheets found at all epithelial-mesenchymal inter- 
faces  and  surrounding  some  types  of individual cells.  The 
collagenous components of these matrices constitute a hetero- 
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molecules composed of chains whose synthesis is directed by 
at least ten separate genes (for review see reference 5). Numer- 
ous biochemical, biosynthetic, and immunocytochemical stud- 
ies  have  been  performed  to  determine  the  cell  and  tissue 
distribution of the collagens. The results obtained for collagen 
types  I-IV have  generally  been  in  agreement  that  different 
collagens  occur  preferentially  in  either  stromal  matrices  or 
basement  membranes,  but  not both.  In adult  organisms, the 
interstitial  collagens, types I, II, and III, are thought to occur 
chiefly in stromas, and type IV exclusively in basement mem- 
branes.  In  early  avian  embryos,  however,  some  interstitial 
collagens  may  also  be  found  transiently  in  the  specialized, 
basement-membrane-like  matrices of the cornea  (21,  23,  31, 
60) and the notochord (30, 36). 
In the case of  type V collagen, however, seemingly conflicting 
results have been the rule rather than exception, with respect 
to both the structure of the molecule(s) and their tissue distri- 
bution and in situ location. Part of the problem may result from 
molecular heterogeneity, since type V collagen may in reality 
constitute a class of distinct but related molecules. As originally 
isolated from a pepsin digest of human placenta (8,  10), type 
V  contained two different a-chain sized polypeptides termed 
aA and aB, now designated a2(V) and a l(V), respectively (see 
reference  5).  Since these  were found in a  ratio  of 1:2 it was 
suggested that these occur as a single, triple-chain heteropoly- 
met,  [al(V)]2a2(V).  Numerous  subsequent  studies  have  sug- 
gested  that  this  indeed  may  be  the  predominant  molecular 
species of type V collagen found in most tissues (3, 24, 28, 41, 
53, 54). Results have also been obtained suggesting, at least in 
some cases, that a portion of the a 1  (V) chains may be assembled 
in a triple-chained homopolymer [al(V)]3 (12, 29, 38, 45, 49); 
in one cell line this is the only molecule assembled (14,  20). 
Some  tissues  also  contain  small  amounts  of a  molecule(s) 
containing a third chain, the aC or a3(V) chain (6, 7), and it 
has been suggested that molecules of composition a I(V) a2(V) 
a3(V) may also occur (51). 
Additional sources of molecular heterogeneity have recently 
been suggested by in vitro biosynthetic experiments.  Several 
different  studies  have  shown that  the chains  of the  smallest 
type V  molecule produced are considerably larger than their 
counterparts  produced  by limited  pepsin  digestion  (28,  35). 
This suggests that the type V  molecules which are normally 
incorporated into tissues may be in forms resembling "partially 
processed" procollagen molecules containing noncollagenous 
extensions (29). Possibly even other peptides may be covalently 
bound to the molecules (14). 
Since the initial  isolation of type V  collagen was from the 
basement-membrane-rich  placenta,  and  since  the  al(V)  and 
a2(V) chains have certain compositional similarities  to those 
of type IV collagen, it was suggested that basement membranes 
could be the no-mal in situ  location. Subsequent biochemical 
analyses showed the corneal stroma to have a relatively high 
concentration of this collagen (11, 24, 46, 58, 61, 62). Since this 
structure is devoid of basement membranes, an exclusive base- 
ment-membrane location of the molecule is unlikely. 
Immunocytochemical studies  with conventional antibodies 
against  [al(V)]2a2(V)  molecules  have  also  seemingly  given 
inconsistent results and have raised further questions as to the 
in  situ  localization  of type  V  collagen(s).  Stenn  et  al.  (55) 
reported that antibodies produced against [al(V)]2a2(V) mol- 
ecules  stained  the  epidermal  basement  membrane  of mouse 
skin, and Bailey et al.  (1) reported similar results for skeletal 
muscle in which their antibodies located this molecule in the 
endomysium (see  also 4 and 39). Conversely, P6schl and von 
der  Mark  (46)  have  reported  that  their  antibodies  against 
[al(V)]2a2(V) collagen (59) give a reaction pattern similar to 
that of type I collagen, staining, for example, the entire cornea. 
Antibodies produced against native type V collagens and sub- 
sequently affinity purified against isolated al(V)  chains give 
yet other staining patterns.  With these, staining appears peri- 
cellularly (17,  18, 40),  as well as in association with  striated 
collagen bundles (40). This has led to the suggestion that some 
type V may function as a bridge between basement membranes 
and connective tissues. 
We  felt  that  at  least  some  of the  apparently  inconsistent 
results  might be  resolved  by an  immunocytochemical study 
with anti-collagen mouodonal antibodies (32, 34) against type 
V. In this present report we describe the production, isolation, 
and characterization of two monoclonal antibodies specific for 
different  antigenic  determinants  in  native  type  V  collagen 
isolated from chicken gizzard. In addition, we present immu- 
nocytochemical evidence that a major in situ  location of type 
V molecules containing these determinants is in dense connec- 
tive  tissue  stromas.  However, the determinants  are  normally 
inaccessible to antibodies unless the tissues are subjected to an 
"unmasking" procedure to be described. 
MATERIALS  AND  METHODS 
Preparation of Collagens:  Chick collagen types III, IV, and V were 
obtained by limited  pepsin extraction of adult chicken gizzard  and separated by 
fractional salt precipitations (42, 43). Some preparations of type IV were further 
purified by ion exchange column chromatography on CM-cellulose  (42, 43), and 
some of type V on DEAE-cellulose (3), both run under non-denaturing condi- 
tions.  Highly purified type V  was also prepared by dialysis  of fractional-salt- 
separated type V against 2 M urea, 0.02 M NaCI, 0.05 M Tris HCk pH 8.6 (44, 
50). In this procedure, type V collagen is precipitated whereas minor amounts of 
other collagens, if present, remain in solution. Type I collagen was an acid extract 
of lathyritic  chick  skin,  and type II a  pepsin extract  of adult  chicken  sterna 
purified as previously described (32, 34). 
Characterization of the type V preparations was performed by SDS PAGE, 
CM-cellulose  chromatography and amino acid analysis (see Results;  Fig.  1; and 
reference  48). 
Hybridoma Production:  Female SJL/J mice (Jackson Laboratories, 
Bar Harbor, ME) were initially  immunized with 200 #g of type V emulsified in 
complete Freund's adjuvant and injected  subcutaneously. Booster injections (200 
tag) were given intraperitoneally at two weeks (in incomplete adjuvant) and three 
months (without adjuvant) after the first injection.  The mice were rested for 10 
wk, and then were given one final injection (100 #g, without adjuvant) four days 
before using their splenocytes for the hybridoma fusion. 
The procedure used for the production of hybridomas (27)  is described in 
detail  elsewhere (33) and is briefly summarized here. All cultures of hybridomas 
and  the  NS1  myeloma cells  used for hybridoma production  were grown in 
Dulbecco-Modified  Eagle's  Medium  (4.5 g/1  glucose)  (Gibco  Laboratories, 
Grand Island Biological  Co., Grand Island, NY) supplemented with 10% fetal 
calf serum (Sterile  Systems), and gentamycin (50 tag/ml).  Splenocytes  (2 x  10  s) 
were obtained from the immunized mice and fused with myeloma ceils (6 x  107) 
in 35% polyethylene glycol. The cells were suspended in complete medium and 
plated into 96-wel/culture plates at a density of 6 x  104 myeloma cells/well. The 
next  day,  HAT  medium  was added  to  select  for hybridomas.  Hybridomas 
producing desired antibodies (see below) were cloned twice by limiting dilution. 
Immunological Characterization:  Antibodies were characterized 
both by passive hemagglutination as previously described (2) and by ELISA (19, 
49). 
For passive hemagglutination, type V collagen (0.3% solution in 0.1 M calcium 
acetate)  was coupled to human type 0-positive  erythrocytes (10% solution) with 
glutaraldehyde. 100 tal aliquots of the derivatized  erythrocytes (diluted  1:20) were 
then added  to  100-tal portions of spent medium from hybridoma cultures  in 
conical-bottom microtiter wells. The plates were allowed to develop overnight at 
4°C before being scored. 
ELISAs were performed using a Hybridoma Screening Kit (Bethesda Research 
Laboratories, Bethesda,  MD) and lmmulon microtiter plates (Dynatech Labo- 
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in 20 mM sodium carbonate buffer pH 8.6. For most assays, each well was coated 
with 2 #g of collagen. The hydridoma antibody to be examined was added (100 
tA/well), and the plates  were incubated  overnight  at 4°C or for 1 h  at room 
temperature.  Both  gave  equivalent  results.  Subsequent  steps were performed 
according  to  the  Bethesda  Research  Laboratory  directions.  The  wells  were 
washed,  and then incubated  with the enzyme-linked  secondary  antibody (,8- 
galactosidase-conjugated  sheep anti-mouse  IgG)  for 2 h at room temperature. 
The wells were washed again, and the p-nitrophenyl-fl-D-galactoside substrate 
was added and allowed to react for 1 h at room temperature.  The reaction was 
stopped by the addition of 0.5 M Na2COa, and the wells diluted with H20 to a 
final  volume of 0.8 ml and read at 414 nm in a  Gilford  spectrophotometer 
(Gilford Instrument Laboratories, Oberlin, OH). 
Inhibition  ELISAs  were  performed  using  nonequilibrium  conditions  (49). 
Aliquots of the collagens in phosphate-buffered  saline  (PBS) (pH 7.1), were 
added to the culture medium antibody,  diluted as specified in the results, and 
reacted  overnight  at 4°C.  100-#1 portions  of the mixture  were  added to the 
collagen-coated wells and incubated  for I h at room temperature  to allow free 
antibody  to bind.  Succeeding steps in the assay were performed  as described 
above. 
Antibody Binding to Thermally Denatured  Collagen:  In 
some ELISA experiments, the inhibitory  collagens in PBS (pH 7.1), were first 
heated at the desired temperature for 0.5 h, and then were rapidly cooled to 0°C 
to  prevent  renaturation.  These  samples  were  used  in  inhibition  ELISAs  as 
described above. 
Measurement of the Thermal Denaturation Temperature 
of the  Type  V Collagen Helix:  The helical structure  of the type V 
collagen  was  monitored at  a  wavelength  of 221  nm  in  a  Cary  Model 61 
spectrapolarimeter equipped with a 1-cm water-jacketed flow cell and an internal 
thermocouple.  The temperature  of the collagen sample  (250 #g/ml in 0.4 M 
NaC1, 20 mM Na phosphate buffer, pH 7.4) was increased at a rate of 30°C/h. 
The total time of UV exposure at 221 nm was kept to <15  rain. to minimize 
damage by ultraviolet irradiation (22). 
Immunofluorescence Histochemical Observations:  Flu- 
orescence histochemistry was performed on frozen sections of organs from 18-d 
chick embryos. The freshly removed organs were dropped into freon cooled to its 
freezing point with liquid N~. The tissues were mounted in OTC Compound 
(Tissue Tek), 8/am sections were cut on a cryostat and placed on 12-spot glass 
slides (Shandon Scientific, Sewicklay, PA). Each section was covered with a drop 
of  culture supernatant  antibody, and the slides were incubated overnight at 4°C. 
The slides were rinsed in PBS (pH 7.4), incubated  with rhodamine-conjugated 
goat anti-mouse lgG diluted  1:50 (Cappel Laboratories, Cochranville, PA) for 1 
h at room temperature,  rinsed again in PBS and mounted in glycerol-PBS. As 
controls, duplicate  slides were stained  with several different  monoclonal  anti- 
bodies specific for different domains of type IV collagen (15), or others specific 
for lens fiber cells (16). 
Before application of the antibodies, some slides were pretreated.  The treat- 
ments included: (a) pepsin (0.1 ~tg/ml) in 0.5 M HAc, 0.5 h, 22°C; (b) HAc (0.5 
M, 0.1 M, and 0.01 M), 0.5 h, 22°C; (c) 0.1 M HAc containing pepstatin (20 #g/ 
ml), EDTA (25  raM),  phenylmethylsuffonylfluoride  (PMSF:  100 ~g/ml),  and 
paramercuribenzoate (100 t~g/ml). 
Observations were usually done blind. Photographs  were taken with Kodak 
Tri-X film rated at ASA 1,600 and developed in Diafme developer. 
RESULTS 
Characterization of the Type V Collagen 
The  type V  collagen  preparations  used  as  an  immunogen, 
and  for routine  screening and assay of antibodies by ELISA, 
were  pepsin  extracts  of adult  chicken  gizzard  in  which  the 
different collagen types had  been separated  by fractional  salt 
precipitations  (42,  43).  For some ELISA  experiments, type V 
collagen preparations were further purified by DEAE-cellulose 
chromatography  performed  under  nondenaturing  conditions 
(3), and precipitation from 2 M  urea at alkaline pH as described 
in Materials and Methods and (50). 
When  analyzed  by SDS  PAGE  and CM-cellulose chroma- 
tography,  all  preparations  of type  V  collagen  were  identical. 
As  can  be  seen  in  Fig.  1  inset,  SDS  PAGE  analyses  of the 
preparations  showed  prominent  bands  of  al(V)  and  c~2(V) 
chains, two slower migrating bands corresponding to fl-chain 
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FIGURE  1  CM-cellulose chromatography and SDS  PAGE of one of 
the type V  collagen preparations used in the present investigation. 
The CM-cellulose chromatogram shows major peaks corresponding 
to al (V)  and a2(V) chains and a small "post al(V)" chain peak. The 
material in  the "post al(V)"  peak is,  by all other criteria,  indistin- 
guishable from an t~l (V) chain (see text). The ratio of al (V)  to a2(V) 
chain is about 2:1. Note the negligible size of the forepeak in which 
most  noncollagenous  materials,  if  present,  would  elute.  The  SDS 
PAGE gel (insert)  shows predominant bands corresponding to at (V) 
and a2(V)  chains, two slower bands of fl-chain  dimers, and a very 
small amount of diffuse material migrating slower than theft-chains. 
dimers, and a  very small amount of diffuse material migrating 
slower than  the fl-chains.  Preparations  of denatured  material 
chromatographed  on  CM-cellulose  columns  (Fig.  1)  showed 
major peaks of the a2(V)  and cd(V) chains, and a  small peak 
eluting later than al(V),  (labeled post cd(V)). The  identity of 
all  peaks  was  verified  by  amino  acid  analysis,  and  by  SDS 
PAGE of both the intact chains and the CNBr peptides derived 
from them (data not shown). By these criteria, the major peaks 
were  al(V)  and  a2(V).  The  material  in  the post c~l(V) peak 
was  indistinguishable  from cd(V),  and  probably  represents a 
modified  form  of the  al(V)  chain  (Mayne  and  Zettergren, 
unpublished results). From the areas of the CM-ceUulose chro- 
matographic peaks, the ratio of a 1  (V) [including post a 1( V)] to 
a2(V)  is  2:1  (range  1.97-2.28,  six  preparations).  Thus,  most 
probably the predominant, if not exclusive, form of the type V 
collagen  used  in  this  study  had  the  chain  composition 
[od(V)]~a2(V). 
Hybridoma Production and Selection 
The  hybridoma  cultures  were  produced  by  fusion  of NS1 
myeloma  cells  with  splenocytes  from  a  type  V-immunized 
mouse, and antibody-positive clones were selected by passive 
hemagglutination with type V  collagen-coated erythrocytes. Of 
960  culture  wells tested,  19  were positive.  Two  were  selected 
for  their  high  hemagglutination  titers,  their  specificity  in 
ELISA (described below), and their stable antibody production 
upon  cloning.  They  were  designated  V-DH2  and  V-ABI2. 
Both were cloned by limiting dilution;  spent culture  medium 
from the resulting clones was used as a  source of antibody in 
all subsequent studies. 
Immunoglobulin Analysis 
The immunoglobulin class to which each of the hybridoma 
antibodies belonged was determined by double immunodiffu- 
sion against heavy-chain-specific, anti-mouse immunoglobulin 
antibodies. Both V-At~I2 and V-DH2  are IgGs. Clones of V- 
AB 12 belong to the IgGl  subclass; those of V-DH2  belong to 
IgG2b. Antibody Characterization  and Specificity 
Characterization of the antibodies was continued by ELISA 
and inhibition ELISA performed under nonequilibrium con- 
ditions according to Rennard et al. (49). Wells coated with 2 
#g of the collagen produced a strong colorimetric reaction (Fig. 
2), yielding highly reproducible results. Digestion of the colla- 
gen used to coat the wells, or of coated wells themselves, with 
highly  purified bacterial collagenase in  the  presence  of the 
protease inhibitors N-ethylmaleimide (2  mM)  and  PMSF  (1 
mM) (46) abolished antibody binding (data not shown). 
For the inhibition ELISA, we wanted to use a concentration 
of antibody  sufficient  to  produce  a  maximum  colorimetric 
reaction  without  having  a  large  antibody  excess.  This  was 
determined by examining the  reaction produced  by twofold 
serial dilutions of each hybridoma culture supernatant (Fig. 2). 
The  reaction  with  V-AB12  began  to  decrease  between  the 
second and  third serial dilution, and  no  significant reaction 
was  obtained  after  the  seventh  one  (an  absolute  antibody 
dilution of 1/128). The maximum reaction with V-DH2 began 
to  decrease  between  the  third  and  fourth  dilutions and  ap- 
proached a minimum at the eighth. From these data, we chose 
to perform all the inhibition ELISAs using antibody V-ABI2 
at a dilution of 1:5 and V-DH2 at  1:10. 
The collagen-type specificity of the two different antibodies 
was determined by inhibition ELISA, using purified collagen 
types  I-V  as  inhibitors  (Fig.  3).  Strong  inhibition  of both 
antibodies was obtained with type V  collagen as well as with 
the alkaline-urea purified preparation (Fig. 3, solid line). Nei- 
ther antibody showed detectable inhibition by collagen types 
I-IV (Fig. 3, dashed line). Nor were they inhibited by any of 
the  minor  "type  V-like"  collagens  from  cartilage  (Mayne, 
Sanderson  and  Linsenmayer,  unpublished  observations,  see 
Discussion). 
As can be seen in Fig. 2, we consistently observed that the 
maximum colorimetric reaction produced by antibody V-DH2 
was considerably greater than that produced by V-AB12. Two 
possibilities could explain this observation. One was that both 
antibodies are against the same antigenic determinant, but V- 
DH2  binds  with  a  greater  affinity.  The  other  was  that,  in 
addition to affinity differences, each was also against a different 
antigenic site(s) within the molecule. 
To distinguish between these, we used the ELISA to compare 
binding  of mixtures  of the  two  antibodies  to  that  of each 
individually, to  see if they would  be  additive. If both  were 
against the same antigenic site, the amount of antibody bound 
from the mixture should be no greater than that of the individ- 
ual antibody with the  higher affinity. If,  however, each  was 
directed against a  different determinant, the amount  of anti- 
body bound from the mixture should be expected to be addi- 
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FIGURE  3  Inhibition  ELISA of  monoclonal antibodies V-AB12 and 
V-DH2 using different types of collagens. Inhibitor collagens at the 
concentrations shown were preincubated overnight at 4°C with the 
monoclonal antibodies. Then, to assay for free antibody, each inhib- 
itor-antibody  mixture  was  added  to  a  microtiter  well  previously 
coated with 2/Lg of type V collagen and incubated at room temper- 
ature for  I  h.  The amount of  antibody that  bound  to the type V 
collagen-coated well was assayed by an enzyme-linked, fl-galacto- 
sidase-antibody reaction, performed as described in  Materials and 
Methods and read at 414 nm. Solid line, inhibition produced on the 
two different antibodies using type V collagen as an inhibitor: open 
circles and open  squares  are with  V-AB12,  and closed circles and 
closed  squares  are  with  V-DH2;  squares  are with  conventionally 
purified type V collagen and circles are with alkaline-urea-purified 
type V. Dashed line, inhibition produced by collagen types I-IV on 
antibody V-DH2:  X's, type I; asterisks,  type II;  open triangles, type 
III; and closed triangles, type IV. A similar complete lack of inhibition 
was observed when  these collagens (I-IV)  were used as inhibitors 
with antibody V-AB12 (not shown). 
FiGUrE  4  ELISA  absorbance 
values  produced  by  twofold 
serial  dilutions  (-log2)  of 
monoclonal  antibody-con- 
taining  culture  supernatants 
by hybridomas V-AB12 and V- 
DH2,  and equivalent 1:1  mix- 
tures  of  the  two  antibodies. 
ELISA performed  as described 
in Materials and Methods and 
read at 414 nm. 
tive. Fig. 4 shows the ELISA results obtained from a  series of 
twofold dilutions of V-AB 12 and V-DH2 compared to a series 
of dilutions made from a mixture of the two. The data clearly 
show,  at  each  antibody  concentration,  that  the  mixture  is 
greater than  either individual. At higher concentrations they 
are essentially additive, suggesting that each is directed against 
a different determinant. 
Further characterization of the antigenic sites was obtained 
by examining their conformational dependency. In collagens, 
conformational-dependent determinants are generally thought 
to occur within the body of the molecule, and to require an 
intact triple helix for their generation (for reviews see references 
30 and 56).  Upon denaturation of the collagen, such a  deter- 
minant  would cease to exist.  In addition, the  helical confor- 
mation  within  a  collagen  generally  melts  at  a  temperature 
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become  denatured.  Thus,  a  positive correlation between  the 
melting temperature of the collagen helix and a loss of antibody 
binding  would  provide  strong  additional evidence  that  the 
antibodies were indeed directed against collagen. 
The  conformational dependence of the antigenic determi- 
nants was examined by inhibition ELISA, using as inhibitors 
type V collagen samples that had been heated to progressively 
higher temperatures. The data were then compared to a thermal 
denaturation curve of the same type V  collagen obtained by 
optical rotation measurements at 221  rim. As can be seen in 
Fig. 5, the melting curve of helicity obtained by optical rotation 
(solid line) was very similar to that of the temperature-depend- 
ent  loss  of binding  of the  two  antibodies  as  measured  by 
competition ELISA (dashed line and slashed line). The major 
changes in optical rotation of the collagen occurred between 
39 °  and 43°C with a midpoint of about 41°C,  similar to that 
reported for both chick type V collagen (57) and type I collagen 
(22) at neutral pH. The curve generated by the temperature- 
dependent loss of antibody binding of V-AB12, over most of 
its length was almost congruent with that of helicity; the one 
produced by antibody V-DH2 was similar but -1.5°C higher. 
Both antibodies appeared to show some slight, but still detect- 
able changes in binding at higher temperatures, a result which 
was more noticeable with V-DH2 than V-AB 12. At present we 
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TEMPERA  TURE 
FIGURE  5  Comparison of the thermal melting curve of the helical 
structure  of  type V  collagen with  the thermal  destruction  of  the 
antibody-binding  sites  against  which  the  type  V  antibodies  are 
directed. The melting curve of the collagen helix was obtained by 
optical  rotation  measured  at  221  nm  (solid  line,  % helicity).  The 
thermal destruction of the antigenic determinants was determined 
by inhibition ELISA, using collagen samples which had been heated 
to progressively higher temperatures as inhibitors. The ELISA values 
are recorded as the percent of the maximum absorbance recorded 
at  414  nm  compared  to  wells  with  no  inhibitor collagen  added. 
Slashed  line, ELISA values obtained with antibody V-AB12. Dashed 
line, ELISA values obtained with antibody V-DH2. 
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do  not  know  whether  (a)  this reflects the  normal statistical 
distribution of native and  denatured  antigenic determinants 
generated  at  the  different  temperatures,  (b)  a  greater  than 
average thermal stability of some portions of the molecule as 
also suggested by the enzyme digestion experiments of Sage et 
al. (54),  or (c) renaturation of a  small portion of the determi- 
nants during the subsequent incubation period with antibody. 
Fluorescence Immunohistochemistry 
Antibodies V-ABI2 and V-DH2 were used as the primary 
antibodies for immunofluorescent staining of cryostat sections 
of unfixed corneas and other tissues from  18-d-old chick em- 
bryos. The results obtained with these were largely negative. 
In fact, in the organs examined the only structure exhibiting 
strong fluorescence was Bowman's membrane (Fig. 6A). Or- 
gans which showed no staining at all were skeletal muscle (Fig. 
7A),  large  blood vessels (Fig. 7D)  and  heart  ventricle (not 
shown).  Light staining was  observed in  the  corneal stroma, 
probably extending into Descemet's membrane  (Fig. 6A).  It 
was  also  discernible  in  the  connective  tissue  layers  of the 
gizzard (Fig. 6 D, arrowheads). 
There were at least two possible reasons for this paucity of 
staining.  The  antibodies  could  have  been  directed  against 
largely artifactual determinants proteolytically  generated in the 
type V collagen either by the pepsin used in its isolation or by 
endogenous tissue proteases. Alternatively, the lack of antibody 
staining  might  be  the  result  of in  situ  unavailability of the 
antigenic determinants, due either to masking by juxtaposed, 
noncollagenous molecules or steric hindrances created during 
assembly of the type V molecules into a supramolecular struc- 
ture. 
To try to obtain more positive staining, we pretreated tissue 
sections either with dilute pepsin dissolved in 0.5 M HAc, and, 
as a control, with the HAc solution itself. After washing with 
PBS,  the  tissues  were  reacted  with  antibodies.  The  initial 
experiments were  performed  on  sections of cornea  with  at- 
tached scleral tissue, and subsequently on sections of the other 
tissues. 
Both pretreatments resulted in dramatic new staining in the 
cornea, very similar to that shown in Fig. 6 C which had been 
pretreated with a lower concentration of HAc (0.1  M). The 0.1 
M  HAc pretreatment (but not 0.01  M) resulted in staining at 
least as bright  and  extensive  as  did the  0.5  M  HAc or the 
pepsin, and in addition maintained better tissue structure. In 
the  pretreated  corneal  sections,  the  stroma  and  Descemet's 
membrane,  which  had  been  only lightly stained in  sections 
without pretreatment, now stained brightly. Bowman's mem- 
brane,  which  had  been  positive  in  the  untreated  sections, 
remained so in the acid pretreated ones. The bright staining of 
all three corneal structures became noticeably diminished at 
the corneal-scleral border. 
The staining produced by both the pepsin and HAc treat- 
ments was specific for the anti-type V collagen antibodies, and 
was not due to a general increase of IgG binding. As a control 
we always processed identically pretreated sections, substitut- 
hag for the primary anti-type V  antibody a  high titer mono- 
clonal against type IV (basement membrane) collagen (15). As 
can be seen in Fig. 6 B, with this latter antibody neither the 
acid nor the pepsin (not shown) pretreatments produced any 
corneal staining,  not  even  of the  epithelial basement  mem- 
brane.1 
The absence of detectable staining of the corneal epithelial basement FIGURE  6  Fluorescence  micrographs  obtained  using  the anti-type V  monoclonal  antibodies for  indirect  immunofluorescence 
staining of sections of cornea plus sclera  (A and C) and gizzard (D and E) from 17-d-old embryonic chicks. A and D were obtained 
by staining  fresh,  untreated  tissue  sections with  the anti-type V  collagen antibodies.  Note  in  the cornea the  relatively strong 
staining of  Bowman's membrane (A,  Bow.  mere.)  and the light staining 6f the stroma.  In the gizzard (D),  the connective tissue 
layers  (arrowheads) show very light staining. The results in  C and  E were obtained with sections that had first been treated with 
0.1 M  HAc before staining with antibody. In the treated cornea (C) extremely bright staining was observed extending from directly 
beneath  the epidermal cell  layer  (epi.)  to  the endothelial cell  layer.  Thus  staining  is  obtained  in  Descemet's  and  Bowman's 
membrane layers as well as the stroma proper. The staining decreases at the corneal-scleral junction, being noticeably less intense 
in the sclera.  Staining is also observed in the connective tissue of the eyelid (lid).  In the treated gizzard (E), staining is localized 
in the dense connective tissue bands that run between the layers of smooth muscle.  B and  F are acid-pretreated sections stained, 
for purposes of comparison, with a high titer, IgG  monoclonal antibody specific of chick type IV (basement membrane) collagen 
(15).  B shows the anterior portion of the cornea, and  F shows the gizzard. In the cornea there is a comptete absence of staining, 
even of the epithelial basement membrane which is one basement membrane we have found to be negative with all of our anti- 
type IV  monoclonal  antibodies  (see reference  15). 1 The gizzard shows anti-type  IV staining to  be associated with  the smooth 
muscle layers,  but none in the intervening connective tissue layers which stain with the anti type V antibodies. 
Since acid pretreatment  alone produced  increased  staining, 
the possibility of artifactual determinants  produced  by pepsin 
membrane  with  the  anti-type  IV  collagen monoclonal  antibody  is 
indeed correct. This antibody, which is against a specific helical domain 
of the type  1V  molecule (15), produces  little if any staining of this 
basement membrane. It does, however, stain the basement membranes 
of most other tissues  (see reference 15, and Figs. 6F, and 7 C and F). 
Using monoclonal antibodies we have produced against other domains 
of type IV, we have observed a similar lack of staining of the corneal 
epithelial basement  membrane  but  extensive staining of most  other 
basement membranes (unpublished observations). 
was  eliminated;  other  results  suggest  that  endogenous  tissue 
proteases are also not involved. When sections were pretreated 
with  0.1  M  HAc  containing  a  mixture  of protease  inhibitors 
(see  Materials  and  Methods)  increased  staining  by  the  anti- 
bodies was obtained just as in the absence of these inhibitors. 
The remaining possibility, which at present we consider most 
likely, is that  the acid treatment  facilitates antibody  access to 
the antigenic determinant  by producing swelling, either of the 
entire tissue or of a  type V  collagen supramolecular structure 
within the extracellular matrix. 
Whatever  the  mechanism  of HAc  treatment,  it  is  not  re- 
LINSENMAY[R El AL.  Anti-Type V Collagen Monoclonal Antibodies  129 FIGURE  7  Fluorescence  micrographs  obtained  using  the  anti-type V  monoclonal  antibodies  for  indirect  immunofluorescence 
staining of sections of skeletal muscle (A and B) and large blood vessel wall (D and E) from 17-d embryonic chicks. A  and  D were 
fresh,  untreated tissue sections.  Note the complete absence of staining.  Sections that had  been first  treated with  0.1  M  HOAc 
before staining with  antibody are shown in  B and  E.  In the pretreated skeletal muscle  (B),  bright staining was observed in the 
connective tissue layers surrounding bundles of muscle fibers.  In the pretreated large blood vessels (E),  the major staining was 
observed in fibrous strands, although more diffuse staining was also observed. For purposes of comparison the same monoclonal 
antibody against chick type IV (basement membrane) collagen used in Fig 6 B and  F was used to stain acid-pretreated sections of 
skeletal muscle (C)  and blood vessel (F). These figures again show that acid pretreatment does not produce its effect by causing 
nonspecific binding of IgG to the acid-treated matrices, since the structures stained with the anti-type IV antibodies are entirely 
different from those stained with the anti-type V. The only effect of acid treatment on the staining with the anti-type IV collagen 
antibodies is a  slight  decrease in  the staining  of  certain  basement membranes  (such  as those surrounding  the skeletal  muscle 
fibers) when compared to that of nonpretreated sections stained with this antibody (not shown, see reference 15). 
stricted  to  corneal  matrices.  We  have  observed  greatly  en- 
hanced staining of  specific extracellular matrices in most organs 
examined. For example, in sections of pretreated gizzard (Fig. 
6 E), the anti-type V collagen antibodies  brightly stained the 
fibrous connective tissue layers, whereas, before treatment the 
same bands showed only very light staining (compare Fig. 6 D 
and E).  In the acid-pretreated gizzard stained  with anti-type 
IV (basement membrane) collagen antibody as a control (Fig. 
6 F),  all  staining  was  associated  with  the  layers  of smooth 
muscle cells  which alternate  with the fibrous ones. Thus, the 
antibodies against the two different types of collagens produce 
essentially reciprocal staining. 
In acid-pretreated skeletal muscle, the anti-type V staining 
(Fig. 7 B) was located in the connective tissue layers surround- 
ing bundles of  muscle fibers.  No detectable staining was present 
in the basement membranes surrounding the individual muscle 
fibers  or in  those  associated  with  intervening  capillaries.  In 
acid-pretreated  sections  reacted  with the  anti-type IV (base- 
ment membrane) collagen antibody (Fig.  7 C),  the basement 
membranes of these latter two structures stained brightly.  2 In 
2 In most tissues, the basement membrane staining produced by the 
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antibody staining  in  fibrous strands  (Fig. 7 E,  arrowheads); 
similar strands are found in pretreated sections of heart ventri- 
cle (not shown). When stained with the anti-type IV collagen 
antibody, pretreated sections of large blood vessels show bright 
staining associated with the bands of smooth muscle (Fig. 7 F), 
a  pattern identical to that produced by this antibody in non- 
pretreated sections (not shown). 
In general, then, the staining with these antibodies is pre- 
dominantly localized in what would be  considered to  be fi- 
brous, stromal matrices. 
DISCUSSION 
We have isolated two monoclonal antibodies against different 
antigenic sites within a type V collagen. Several different lines 
of evidence suggest that the antibodies are completely specific 
for  conformational dependent  antigenic  determinants  in,  or 
closely associated with, the triple helical structure of the mol- 
ecule,  and  are  present  in  no  other  known  type  of collagen 
molecule. 
By  passive hemagglutination  with  type V  collagen-coated 
erythrocytes and  by ELISA using type V-coated wells, both 
antibodies gave strong reactions. In competition ELISA they 
were both strongly inhibited by native type V collagen, includ- 
hag  molecules which  had  been  purified  by  DEAE-ceUulose 
chromatography and  by  alkali-urea fractionation.  The  anti- 
bodies were not inhibited by any other collagen types, including 
native molecules containing the  la,  2a,  and  3a  chains from 
cartilage (Mayne et al., unpublished observations) the first two 
of which resemble type V collagen chains (9, 48). These anti- 
bodies then seem to be uniquely specific for type V collagen. 
Treatment of the type V collagen with highly purified bac- 
terial collagenase abolishes the reaction in ELISA, so that the 
antigenic determinants are probably localized in,  or at  least 
closely associated with, a  helical region of the molecule. Ad- 
ditional evidence for such a location is provided by the thermal 
denaturation experiments. In these, the curves generated by the 
loss of antibody binding activity, over most of their length were 
similar to loss of helicity, as determined by optical rotation. 
This  strongly  suggests  that  the  antigenic  determinants  are 
within the collagen molecule itself. An alternative possibility 
which we consider somewhat unlikely, but have not yet been 
able to eliminate, is that the determinants are not within the 
collagen helix, but instead are in a component(s) so intimately 
associated with the helical structure that any conformational 
change in the helix also destroys or changes the structure of 
the hypothetical, bound component(s).  Even if this were the 
case, the bound component itself would still seem to be highly 
specific for type V and no other collagen. In the present study, 
the  collagen types  III  and  IV  were  derived from  the  same 
preparations of gizzard as was the type V, and these did not 
bind antibody. 
The immunocytochemical data we obtained using these anti- 
bodies on  acid-pretreated sections  from  a  variety of tissues 
suggests that a major in situ location for the molecule is dense 
connective tissue, a conclusion also drawn by PiSschl and von 
der Mark  (47).  Little if any staining was found in basement 
membranes as evidenced by comparative sections stained with 
anti-type IV collagen antibody on acid pretreated sections is exactly 
the same pattern as is produced by it with non-pretreated sections (15). 
The only detectable difference is that the staining of some basement 
membranes,  such as those surrounding  skeletal muscle cells, is some- 
what less intense in the acid pretreated sections. 
monoclonal antibodies against type IV basement  membrane 
collagen (15).  The  only exception we have noted thus far is 
Descemet's membrane, one of the specialized basement-mem- 
brane-like structures of the cornea. As shown here, this struc- 
ture gives a strong reaction when stained with the anti-type V 
collagen antibodies; when stained with antibodies against type 
IV collagen, it exhibits a weak, yet generally detectable reaction 
(15). 1  Descemet's membrane, however, is probably not a typical 
basement membrane. At the ultrastructural level it is morpho- 
logically complex (25,  26), and by biochemical and immuno- 
cytochemical analyses, it has been  shown  to  contain several 
different interstitial collagens, as well as type IV (21, 23,  58, 
60).  Our general conclusion, then,  would be that the type V 
collagen against which our antibodies are directed has a tissue 
distribution pattern similar to that of an  interstitial collagen 
such as type I or type III. 
Our results should not, however, be interpreted as eliminat- 
ing the possibility that other type V collagen molecule(s) may 
have tissue distributions different from the ones observed here. 
For example, Gay and co-workers (17,  18) have demonstrated 
a  type V  collagen which occurs in a  pericellular localization, 
although they also fred the molecule closely associated with 
type I collagen fbrils (40).  This latter distribution is consistent 
with our results reported here. Others have reported type V to 
be associated with basement membranes (I, 52, 55). Due to the 
potential heterogeneity of type V  with respect to chain com- 
position and molecular assembly (12,  14, 20,  29,  45, 49) and 
the  presence  of accessory peptides (14),  different antibodies 
may indeed detect antigenic determinants within different type 
V  collagen molecules. In addition, the high degree of in  situ 
masking we have observed leaves the possibility that different 
unmasking procedures might uncover additional locations for 
the molecule(s). Thus, only positive staining can be interpreted 
with any degree of confidence, the absence of staining is very 
much a negative result. 
The staining we have obtained with the anti-type V mono- 
clonal antibodies is consistent with known biochemical data. 
In nonpretreated sections, some structures which have previ- 
ously been shown to contain type V  (i.e. large blood vessels) 
(13,  43),  were  completely  negative  when  stained  with  the 
antibodies. After acid pretreatment, however, staining of con- 
nective tissue elements in these previously negative structures 
became clear-cut, and the staining of other structures that had 
reacted only lightly in untreated tissues became intense. The 
correlation between  biochemical analyses and  immunocyto- 
chemical staining is especially evident in cornea. In acid-pre- 
treated corneas, equally intense fluorescence is observed in the 
stroma  proper  and  both  Bowman's  and  Descemet's  mem- 
branes. Biochemical analyses from several different laborato- 
ries (ll, 26, 46,  58,  61,  62) have shown corneas to be rich in 
type  V  collagen,  with  each  of the  connective  tissue  layers 
containing it in approximately the same percentage (58). 
We do not know for certain the mechanism of unmasking 
by the acid pretreatment, but since it works in the presence of 
protease inhibitors, proteolytic changes are probably not in- 
volved. Our current working hypothesis is that the unmasking 
is due to swelling, either of the entire tissue or more probably 
of a  supramolecular structure  in  which the  type V  collagen 
molecules may be arranged. It is not known in what fibrillar or 
other supramolecular form(s) type V  collagen molecules are 
arranged  in  situ.  However,  if they  are  conformationally ar- 
ranged such that the antigenic determinants are unavailable to 
the antibody, simple swelling of the structure by the acid may 
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The same mechanism of unmasking could work, for example, 
if type V  collagen molecules were  arranged within, or com- 
plexed with, fibrils composed largely of another collagen such 
as type I, a possibility that has been suggested previously (40, 
47). In this case, the absence of complete masking in structures 
such as Bowman's membrane and the cornea stroma could be 
due to a different supramolecular arrangement of a portion of 
the molecules or to the presence of newly synthesized molecules 
that have not yet completely assembled. Alternatively, the low 
pH treatment could work by inducing conformational changes 
in  masking substances,  such  as  giycoproteins  (37),  or  even 
within the structure of the type V collagen molecule itself. We 
are currently trying to distinguish among these possibilities. 
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